Deutsch Englisch   
 

AdAM (Application for Digitally Supported Pharmacotherapy Management)

Scientific project leader

Prof. Dr. Holger Pfaff

Dr. Ute karbach

Project execution

Sara Söling

Cooperation partner

Barmer GEK

KV Westfalen Lippe

Prof. Ferdinand Gerlach, Institut für Allgemeinmedizin, Universität Frankfurt

Prof. Hans Trampisch, Abteilung für Medizinische Informatik, Biometrie und Epidemiologie, Medizinische Fakultät der Ruhr-Universität Bochum

Prof. Wolfgang Greiner, Lehrstuhl für Gesundheitsökonomie und Gesundheitsmanagement, Universität Bielefeld

Dr. Ingrid Schubert, PMV forschungsgruppe, Universität Köln

Funding institution

Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project duration

10/2016 - 09/2019

Project description

Many elderly people suffer from multimorbidity and require several drugs simultaneously. The medical treatment of these patients brings with it an increased risk of drug interaction, side effects and medication errors.

AdAM contains specially developed software, which offers physicians digital support to improve the quality, safety and coordination of pharmacotherapy and healthcare management. The software has various functions, such as:

1) Extracting treatment-relevant patient information from health insurance carrier routine data in real time with the patient’s informed consent

2) Conducting electronically supported drug safety tests and printing the required standard German drug charts in various languages for patients

3) Sending automatic risk warnings in the event of medication errors

4) Automatic notifications when outpatients are admitted for inpatient treatment and coordinating drug administration with the hospital

IMVR will conduct the formative evaluation of the new AdAM form of healthcare, thus presenting which factors conducive and restrictive to implementation may be observed in the application of this digitally supported pharmacotherapy management. Participating general practitioners in the control group and intervention group will be asked questions regarding those factors conducive and restrictive to implementation (user-friendliness of the software, obstacles) in guided telephone interviews and focus groups will be organized with those who have been using the application for a while and those who have started using it recently. Based on the results of this qualitative data collection, a postal survey (quantitative) will be developed and employed in participating practices to record factors relevant to physicians and practices. Qualitative evaluation will either be content analytical or qualitative descriptive, depending on the issue being addressed. The survey will be descriptive.